Janet Chollet

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.

Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA

Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ

Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.

Chitina Sciences, Inc. operates as a development stage company. The company is headquartered in New York, NY.

Cordova Sciences, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on August 12, 2005 and is headquartered in New York, NY.

Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA.

NX Development Corp. operates as a life science company. It develops Gleolan oral solutions which helps in identifying malignant glioma, a type of brain tumor in adult patients. It allows surgeons to visualize brain tumors during surgery. The company was founded by Alan Ezrin and is headquartered in Lexington, KY.

Wyrick Robbins Yates & Ponton LLP is a full-service law firm that focuses on growth-oriented businesses. The private company is based in Raleigh, NC, and has subsidiaries in the United States. The firm offers legal services in various areas, including appellate litigation, banking and financial institutions, commercial litigation, commercial real estate, emerging companies, employee benefits and executive compensation, environmental, regulatory and administrative law, family law, government contracting, healthcare, investment funds, labor and employment, licensing and technology transactions, mergers and acquisitions, privacy and data security, tax, trademarks, and trusts and estates.

Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million.

Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA.

Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york.

The Rogosin Institute, Inc. engages in providing treatment for kidney diseases. The company was founded in 1983 and is headquartered in New York, NY.

Cortice Biosciences, Inc. manufactures pharmaceutical products. The company is headquartered in New York.

OncoNano Medicine, Inc. operates as a biotechnology company. It develops pH-activated compounds that digitalize and exploit the variability of pH in disease. The company was founded by Ravi Srinivasan, Jinming Gao, and Baran Sumer in 2014 and is headquartered in Southlake, TX.

Integrin Partners LLC provides advisory services to the life science industry.

SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA.

RIGImmune, Inc. is a platform biopharmaceutical company based in Farmington, CT, with subsidiaries in the United Kingdom. The company is developing a novel investigational class of RNA immunotherapies called "SLRs" for the potential pan-viral treatment and prophylaxis of viral respiratory diseases and selected cancers. The lead development candidate at RIGImmune is RIG-101, which specifically modulates RIG-I, a host surveillance pathway that triggers the innate immune system to enhance an intrinsic response to RNA viruses, including influenza, RSV, rhinovirus, and SARS-CoV-2, and tumor DNA. The company was founded in 2020 by Akiko Iwasaki and Anna Marie Pyle, both prominent Yale University professors who currently serve as scientific advisors to the company.

NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.